Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome

NCT05034770 is registered in ClinicalTrials.gov with Emine Dundar Ahi, MD as lead sponsor.

NCT NCT05034770
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05034770 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Major Ozone Autohemotherapy in the Treatment of Fibromyalgia Syndrome
Lead sponsor
Emine Dundar Ahi, MD
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
January 11, 2022
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fibromyalgia syndrome